David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$826M |
| 2 |
Microsoft
MSFT
|
+$549M |
| 3 |
Pinduoduo
PDD
|
+$305M |
| 4 |
Intel
INTC
|
+$274M |
| 5 |
Apple
AAPL
|
+$266M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$382M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$298M |
| 3 |
TWTR
Twitter, Inc.
TWTR
|
+$267M |
| 4 |
Procter & Gamble
PG
|
+$260M |
| 5 |
Meta Platforms (Facebook)
META
|
+$244M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.35% |
| 2 | Healthcare | 8.99% |
| 3 | Financials | 7.94% |
| 4 | Consumer Discretionary | 7.49% |
| 5 | Industrials | 4.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2126
C3.ai
AI
$1.51B
| $4.16M | ﹤0.01% |
371,640
+334,829
| +910% | +$4.19M |
|
2127
Five Below
FIVE
$14.2B
| $4.16M | ﹤0.01% |
23,495
-336
| -1% | -$52.8K |
|
2128
Allogene Therapeutics
ALLO
$705M
| $4.15M | ﹤0.01% |
660,187
+220,492
| +50% | +$2.04M |
|
2129
Verra Mobility
VRRM
$672M
| $4.15M | ﹤0.01% |
299,788
+183,771
| +158% | +$2.79M |
|
2130
Blue Owl Capital
OBDC
$5.55B
| $4.14M | ﹤0.01% |
358,060
+254,146
| +245% | +$3.05M |
|
2131
Pliant Therapeutics
PLRX
$71.8M
| $4.13M | ﹤0.01% |
213,801
-1,514
| -0.7% | -$31.7K |
|
2132
MINISO
MNSO
$3.41B
| $4.13M | ﹤0.01% |
+384,982
| New | +$3.22M |
|
2133
CALL
ScottsMiracle-Gro
SMG
$3.57B
| $4.13M | ﹤0.01% |
+85,000
| New | +$4.26M |
|
|
BRD
2134
DELISTED
Beard Energy Transition Acquisition Corp.
BRD
| $4.13M | ﹤0.01% |
405,200
| – | – |
|
2135
PUT
Wingstop
WING
$3.06B
| $4.13M | ﹤0.01% |
30,000
| – | – |
|
|
ASBP
2136
Aspire Biopharma
ASBP
$11.7M
| $4.13M | ﹤0.01% |
333
| – | – |
|
|
EBAC
2137
DELISTED
European Biotech Acquisition Corp. Class A Ordinary Shares
EBAC
| $4.13M | ﹤0.01% |
408,574
+150,000
| +58% | +$1.5M |
|
2138
Federated Hermes
FHI
$4.86B
| $4.13M | ﹤0.01% |
+113,622
| New | +$3.99M |
|
2139
CALL
Northern Oil and Gas
NOG
$2.77B
| $4.12M | ﹤0.01% |
+133,800
| New | +$4.5M |
|
2140
PUT
Match Group
MTCH
$9.66B
| $4.12M | ﹤0.01% |
99,200
-56,800
| -36% | -$2.57M |
|
2141
Zumiez
ZUMZ
$311M
| $4.12M | ﹤0.01% |
189,290
+99,269
| +110% | +$2.2M |
|
|
ANSS
2142
PUT
DELISTED
Ansys
ANSS
| $4.11M | ﹤0.01% |
17,000
+500
| +3% | +$116K |
|
2143
CALL
Super Micro Computer
SMCI
$24.2B
| $4.11M | ﹤0.01% |
+500,000
| New | +$3.81M |
|
|
PNST
2144
DELISTED
Pinstripes Holdings, Inc.
PNST
| $4.08M | ﹤0.01% |
400,000
| – | – |
|
2145
Syndax Pharmaceuticals
SNDX
$1.79B
| $4.08M | ﹤0.01% |
160,435
+32,407
| +25% | +$756K |
|
2146
PUT
Signet Jewelers
SIG
$3.25B
| $4.08M | ﹤0.01% |
60,000
+29,500
| +97% | +$1.88M |
|
|
CFFS
2147
DELISTED
CF Acquisition Corp. VII Class A Common Stock
CFFS
| $4.08M | ﹤0.01% |
400,000
| – | – |
|
2148
Target Hospitality
TH
$1.67B
| $4.08M | ﹤0.01% |
269,318
+164,769
| +158% | +$2.22M |
|
2149
Pool Corp
POOL
$6.85B
| $4.08M | ﹤0.01% |
13,480
-1,911
| -12% | -$605K |
|
2150
GoodRx Holdings
GDRX
$1.25B
| $4.07M | ﹤0.01% |
874,424
-76,919
| -8% | -$379K |
|
Similar funds
David Shaw's Q4 2022 Portfolio in Review
As of Q4 2022, David Shaw held 5,609 positions worth $90.5B, up 8.1% from $83.7B the previous quarter. Its ten largest holdings account for 8.3% of the portfolio.
David Shaw's Q4 2022 filing shows 475 new, 1,793 increased, 1,541 reduced and 783 closed positions. Its largest new stake was iShares JPMorgan USD Emerging Markets Bond ETF: 3,017,047 shares worth $255M. The largest sale was Berkshire Hathaway Class B, an estimated $382M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Healthcare and Financials.
- David Shaw's largest Q4 2022 buy was iShares JPMorgan USD Emerging Markets Bond ETF: 3,017,047 shares worth $255M.
- David Shaw added most to Tesla in Q4 2022, an estimated $826M increase.
- David Shaw's biggest Q4 2022 reduction was Berkshire Hathaway Class B, cutting an estimated $382M.
- David Shaw fully exited Twitter, Inc. in Q4 2022, selling an estimated $267M.
- David Shaw's ten largest holdings make up 8.3% of its $90.5B portfolio in Q4 2022.
- David Shaw opened 475 new positions and closed 783 in Q4 2022.
- David Shaw's portfolio value rose 8.1% quarter-over-quarter to $90.5B.
Based on D.E. Shaw & Co's 13F filing for Q4 2022, filed 14 Feb 2023.